Basketball Hall-of-Famer Bill Walton Embarks on Patient Seminar Tour With The Better Way Back(R)

Basketball Hall-of-Famer Bill Walton Embarks on Patient Seminar Tour With The 
Better Way Back(R) 
SAN DIEGO, CA -- (Marketwired) -- 06/27/13 --  NuVasive, Inc.
(NASDAQ: NUVA), a medical device company focused on developing
minimally disruptive surgical products and procedures for the spine,
announced today that The Better Way Back(R), a NuVasive-supported
patient education program, will hold two patient seminars in July.  
Bill Walton, Basketball Hall-of-Famer and Patient Ambassador with The
Better Way Back, will co-host both events: 

--  Walton and Dr. Roy Vingan of North Jersey Brain and Spine will co-host
    the first event at Hackensack University Medical Center in Hackensack,
    N.J., on Thursday, July 11, 2013, from 4:00 to 6:00 p.m. EDT.
--  Walton and Dr. Rudolph Buckley of Hamilton Orthopaedic Surgery &
    Sports Medicine will co-host the second event at the Masonic Care
    Community in Utica, N.Y., on July 12, 2013, from 1:00 to 3:00 p.m.

Both patient events are open to the community. To RSVP or to learn more
about The Better Way Back, please visit: or
call 800-745-7099. 
The Better Way Back frequently sponsors patient seminars to educate
preoperative patients on minimally disruptive surgery, including the
XLIF(R) (eXtreme Lateral Interbody Fusion) procedure. 
Recently, Walton and retired MMA fighter, Nate Quarry, spoke about
their spine surgery experiences with preoperative patients at Doctors
Hospital in Augusta, Ga. Walton and Quarry have both undergone XLIF
procedures to help relieve chronic back pain. Today, they are both
living pain-free and have made personal commitments to "pay it
forward." They are Patient Ambassadors with The Better Way Back, a
role that allows them to speak with prospective patients about their
own decisions to undergo XLIF surgery and potential benefits of the
Quarry suffered from degenerative disc disease that prevented him
from training. He was afraid of losing his MMA career and his ability
to provide for his daughter. He eventually opted to undergo the XLIF
procedure in 2006. Just 15 months later, Quarry returned to the
Octagon(TM), winning his comeback fight against an old adversary. 
"To be able to give people hope, to be able to give people the dream
that they may have a chance -- that's why we're here," Quarry said. 
Walton also lived with increasingly unbearable pain. After trying a
number of unsuccessful treatment options, and even contemplating
suicide, he underwent the XLIF procedure in 2009. 
"I just wanted my life -- any life -- back," said Walton.  
After his surgery, Walton was amazed by the relief he experienced
from his excruciating nerve pain. Eager to share his story with
others, he also became a Patient Ambassador with The Better Way Back,
giving hope to others who suffer from back and leg pain. 
In addition to sharing stories with preoperative patients, Patient
Ambassadors routinely speak on behalf of patients who are unable to
speak for themselves. The Better Way Back community raises awareness
with legislative and regulatory decisions makers by providing
educational information about spine disorders, innovative treatment
options, and an overview of patient outcomes. 
For NuVasive press materials please visit:  
About The Better Way Back
 The Better Way Back is dedicated to
building a community that provides hope, support, and valuable
information to patients suffering from chronic back and leg pain. We
are committed to raising public awareness of spine disorders and
educating patients, loved ones, clinicians, and healthcare providers
about treatment options including surgery. Our passionate commitment
is to establish The Better Way Back as the preeminent resource for
chronic back and leg pain information and surgical treatment options. 
About NuVasive
 NuVasive is an innovative global medical device
company that is changing spine surgery with minimally disruptive
surgical products and procedurally integrated solutions for the
spine. The Company is the 4th largest player in the $8.2 billion
global spine market. 
NuVasive offers a comprehensive spine portfolio of more than 80
unique products developed to improve spine surgery and patient
outcomes. The Company's principal procedural solution is its Maximum
Access Surgery, or MAS(R) platform for lateral spine fusion. MAS
provides safe, reproducible, and clinically proven outcomes, and is a
highly differentiated solution with fully integrated neuromonitoring,
customizable exposure, and a broad offering of application-specific
implants and fixation devices designed to address a variety of
Having pioneered the lateral approach to spine fusion, NuVasive
continues to be at the forefront of the spine industry's shift toward
less invasive solutions. The Company places a large focus on clinical
research through its support of the Society of Lateral Access
Surgery, or SOLAS(R), to expand the body of clinical data regarding
minimally disruptive surgical treatment options. The Company's
dedication to innovation continues to spawn game changing technology
such as the PCM(R) motion preserving disc for the cervical spine,
XLIF(R) Corpectomy for tumor and trauma, and Armada(R), which treats
adult degenerative scoliosis in a less invasive fashion. The Company
has also developed procedural solutions that completely redefine and
improve upon traditional procedures like TLIF, PLIF, Posterior
Fixation, and ALIF. NuVasive's solutions are increasingly being
adopted internationally, as the Company lays the groundwork to
continue growing as a global business and to offer industry-leading,
Absolutely Responsive customer service to surgeons world-wide.
NuVasive is focused on becoming a $1 Billion Start-up(TM); taking
market share by maintaining a commitment to Superior Clinical
Outcomes, Speed of Innovation(R), and Absolute Responsiveness(R).  
NuVasive cautions you that statements included in this press release
that are not a description of historical facts are forward-looking
statements that involve risks, uncertainties, assumptions and other
factors which, if they do not materialize or prove correct, could
cause NuVasive's results to differ materially from historical results
or those expressed or implied by such forward-looking statements. The
potential risks and uncertainties that could cause actual growth and
results to differ materially include, but are not limited to those
risks and uncertainties more fully described in NuVasive's press
releases and periodic filings with the Securities and Exchange
Commission. NuVasive's public filings with the Securities and
Exchange Commission are available at NuVasive assumes no
obligation to update any forward-looking statement to reflect events
or circumstances arising after the date on which it was made. 
Image Available: 
Investor Contact:
Tina Jacobsen
NuVasive, Inc.
Media Contact:
Nicole Collins
NuVasive, Inc.
Press spacebar to pause and continue. Press esc to stop.